Media Room  Press Releases 


 
  

Welcome

  

Press Releases

  

Company Info

  

Press Kits

  

Hot Topics

  

Images

  

Events

  

Contacts

  

Articles, Presentations, Posters & Reviews

 
  

ACD/Labs Home

Pfizer Signs Worldwide License Agreement for ACD NMR Software

Media Contact
Tara Sinclair
Media Coordinator
media@acdlabs.com
(416) 368-3435 ext. 297
(416) 368-5596

Latest News
Making the Most of Valuable Laboratory Time at Connecticut College - September 2008

e-mail alerts
RSS feed

NMR Data Management System Integrated with MDL ISIS

TORONTO - March 1, 1999 - Advanced Chemistry Development, Inc. (ACD) today announced that Pfizer, Inc. and ACD have signed a five-year agreement that will provide Pfizer with unlimited, worldwide use of:

  • ACD/NMR Manager
  • ACD/CNMR Predictor and Database
  • ACD/HNMR Predictor and Database

Pfizer chemists now have the ability to retrieve, view and process Pfizer experimental NMR data from the desktop. ACD NMR prediction software and databases will provide chemists with the tools to assist with the assignment of NMR shifts.

In addition, as a result of extensive collaboration with Pfizer, ACD has implemented enhanced versions of its software that seamlessly integrate with MDL ISIS software. "The integration of ACD software with ISIS provides easy-to-use accessibility to our NMR products," said Tim Blacker, Director of Sales at ACD. "Pfizer chemists can now access both experimental and predicted NMR data from the familiar ISIS interface - we think this is an added value to companies with a large investment in ISIS."

Advanced Chemistry Development Inc. (http://www.acdlabs.com) is a leader in the field of physical property prediction, desktop spectroscopy management, systematic naming, and Web-based access to chemistry prediction. Founded in 1993 and with headquarters in Toronto, Canada, the company employs over 90 people and has established worldwide distribution channels. ACD's mission is to define a new standard in capability for chemistry-based software addressing the needs of spectroscopy, physical property prediction, and chemical naming.

Pfizer Inc. (www.pfizer.com) is a research-based, global pharmaceutical company that discovers and develops innovative, value-added products that improve the quality of life of people around the world and help them enjoy longer, healthier, and more productive lives. The company has three business segments: health care, animal health and consumer health care. Pfizer products are available in more than 150 countries.

TOP

This page was last updated 01 October 2007
 

  Products | Solutions | Support
Online Services | Resources
About Us | Downloads | Events
Site Map | Contact Us
 

 
Copyright © 1996 - 2008 Advanced Chemistry Development     All rights reserved